Squarepoint
AQST icon

Squarepoint’s Aquestive Therapeutics AQST Stock Holding History

Squarepoint’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$293K Sell
70,422
-179,060
-72% -$754K ﹤0.01% 3818
2026
Q1 		$1.04M Buy
+249,482
New +$1.01M ﹤0.01% 2754
2025
Q3 		– Sell
-26,034
Closed -$86.2K – 4338
2025
Q2 		$86.2K Buy
+26,034
New +$74.7K ﹤0.01% 4205
2024
Q4 		– Sell
-85,392
Closed -$425K – 5001
2024
Q3 		$425K Buy
85,392
+51,991
+156% +$202K ﹤0.01% 3216
2024
Q2 		$86.8K Sell
33,401
-5,845
-15% -$19.5K ﹤0.01% 3821
2024
Q1 		$167K Buy
+39,246
New +$131K ﹤0.01% 3671
2023
Q4 		– Sell
-75,683
Closed -$116K – 3982
2023
Q3 		$116K Sell
75,683
-47,824
-39% -$82.2K ﹤0.01% 3541
2023
Q2 		$204K Buy
123,507
+107,965
+695% +$195K ﹤0.01% 3216
2023
Q1 		$17.7K Buy
+15,542
New +$13.5K ﹤0.01% 3138
2021
Q3 		– Sell
-19,824
Closed -$79K – 2881
2021
Q2 		$79K Buy
+19,824
New +$79.2K ﹤0.01% 3056
2021
Q1 		– Sell
-42,797
Closed -$229K – 3081
2020
Q4 		$229K Buy
+42,797
New +$256K ﹤0.01% 2415
2020
Q3 		– Sell
-193,856
Closed -$942K – 2473
2020
Q2 		$942K Buy
193,856
+177,431
+1,080% +$817K 0.02% 982
2020
Q1 		$36K Sell
16,425
-2,225
-12% -$8.45K ﹤0.01% 1742
2019
Q4 		$109K Sell
18,650
-22,127
-54% -$115K ﹤0.01% 2331
2019
Q3 		$130K Buy
40,777
+2,587
+7% +$9.69K ﹤0.01% 2155
2019
Q2 		$160K Buy
38,190
+22,190
+139% +$114K ﹤0.01% 2151
2019
Q1 		$111K Sell
16,000
-13,828
-46% -$96.9K ﹤0.01% 2026
2018
Q4 		$188K Buy
+29,828
New +$377K ﹤0.01% 1703

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Squarepoint's AQST Position: Q2 2026 in Review

Squarepoint reduced its Aquestive Therapeutics (AQST) stake by 72% in Q2 2026, selling an estimated $754K and leaving 70,422 shares worth $293K. The position accounts for ﹤0.01% of the portfolio, ranked #3818.

Squarepoint first reported a position in AQST in Q4 2018 and has held it in 18 quarters since. The position peaked at $1.04M in Q1 2026. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Squarepoint held 70,422 shares of Aquestive Therapeutics worth $293K as of Q2 2026.
  • Squarepoint sold 179,060 Aquestive Therapeutics shares in Q2 2026, an estimated $754K.
  • Aquestive Therapeutics made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3818 holding.
  • Squarepoint first reported a position in Aquestive Therapeutics in Q4 2018 and has held it in 18 quarters since.
  • Squarepoint's Aquestive Therapeutics position peaked at $1.04M in Q1 2026.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.